- Home
- LPLA vs CADL Comparison
LPLA vs CADL Comparison
Compare LPLA & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPLA
- CADL
- Stock Information
- Founded
- LPLA 1989
- CADL 1999
- Country
- LPLA United States
- CADL United States
- Employees
- LPLA N/A
- CADL N/A
- Industry
- LPLA Investment Bankers/Brokers/Service
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- LPLA Finance
- CADL Health Care
- Exchange
- LPLA Nasdaq
- CADL Nasdaq
- Market Cap
- LPLA 30.4B
- CADL 234.8M
- IPO Year
- LPLA 2010
- CADL 2021
- Fundamental
- Price
- LPLA $384.11
- CADL $5.10
- Analyst Decision
- LPLA Strong Buy
- CADL Strong Buy
- Analyst Count
- LPLA 14
- CADL 5
- Target Price
- LPLA $379.79
- CADL $21.40
- AVG Volume (30 Days)
- LPLA 644.3K
- CADL 923.7K
- Earning Date
- LPLA 07-24-2025
- CADL 08-12-2025
- Dividend Yield
- LPLA 0.31%
- CADL N/A
- EPS Growth
- LPLA 9.05
- CADL N/A
- EPS
- LPLA 14.44
- CADL N/A
- Revenue
- LPLA $12,896,160,000.00
- CADL N/A
- Revenue This Year
- LPLA $29.17
- CADL N/A
- Revenue Next Year
- LPLA $17.00
- CADL N/A
- P/E Ratio
- LPLA $26.61
- CADL N/A
- Revenue Growth
- LPLA 25.70
- CADL N/A
- 52 Week Low
- LPLA $187.19
- CADL $3.79
- 52 Week High
- LPLA $390.23
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- LPLA 55.43
- CADL 44.91
- Support Level
- LPLA $363.95
- CADL $4.73
- Resistance Level
- LPLA $378.48
- CADL $5.07
- Average True Range (ATR)
- LPLA 9.37
- CADL 0.28
- MACD
- LPLA -0.54
- CADL -0.01
- Stochastic Oscillator
- LPLA 82.09
- CADL 48.38
About LPLA LPL Financial Holdings Inc.
LPL Financial Holdings is an independent broker/dealer that provides a platform of proprietary technology, brokerage, and investment advisory services to financial advisors and institutions. As of the end of 2024, the company had over 29,000 advisors on its platform managing $1.7 trillion of client assets. The company doesn't have material operations outside the United States.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.